Letteratura scientifica selezionata sul tema "Kynurenine - Metabolism"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Kynurenine - Metabolism".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Articoli di riviste sul tema "Kynurenine - Metabolism"

1

Maget, Alexander, Martina Platzer, Susanne A. Bengesser, Frederike T. Fellendorf, Armin Birner, Robert Queissner, Carlo Hamm, et al. "Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder." Current Topics in Medicinal Chemistry 20, no. 15 (June 1, 2020): 1344–52. http://dx.doi.org/10.2174/1568026619666190802145128.

Testo completo
Abstract (sommario):
Background & Objectives: The kynurenine pathway is involved in inflammatory diseases. Alterations of this pathway were shown in psychiatric entities as well. The aim of this study was to determine whether specific changes in kynurenine metabolism are associated with current mood symptoms in bipolar disorder. Methods: Sum scores of the Hamilton Depression Scale, Beck Depression Inventory, and Young Mania Rating Scale were collected from 156 bipolar individuals to build groups of depressive, manic and euthymic subjects according to predefined cut-off scores. Severity of current mood symptoms
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Badawy, Abdulla A. B., and Samina Bano. "Tryptophan Metabolism in Rat Liver after Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors." International Journal of Tryptophan Research 9 (January 2016): IJTR.S38190. http://dx.doi.org/10.4137/ijtr.s38190.

Testo completo
Abstract (sommario):
Rat liver tryptophan (Trp), kynurenine pathway metabolites, and enzymes deduced from product/substrate ratios were assessed following acute and/or chronic administration of kynurenic acid (KA), 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), Trp, and the kynureninase inhibitors benserazide (BSZ) and carbidopa (CBD). KA activated Trp 2,3-dioxygenase (TDO), possibly by increasing liver 3-HAA, but inhibited kynurenine aminotransferase (KAT) and kynureninase activities with 3-HK as substrate. 3-HK inhibited kynureninase activity from 3-HK. 3-HAA stimulated TDO, but inhibited kynuren
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Ruddick, Jon P., Andrew K. Evans, David J. Nutt, Stafford L. Lightman, Graham A. W. Rook, and Christopher A. Lowry. "Tryptophan metabolism in the central nervous system: medical implications." Expert Reviews in Molecular Medicine 8, no. 20 (August 2006): 1–27. http://dx.doi.org/10.1017/s1462399406000068.

Testo completo
Abstract (sommario):
The metabolism of the amino acid l-tryptophan is a highly regulated physiological process leading to the generation of several neuroactive compounds within the central nervous system. These include the aminergic neurotransmitter serotonin (5-hydroxytryptamine, 5-HT), products of the kynurenine pathway of tryptophan metabolism (including 3-hydroxykynurenine, 3-hydroxyanthranilic acid, quinolinic acid and kynurenic acid), the neurohormone melatonin, several neuroactive kynuramine metabolites of melatonin, and the trace amine tryptamine. The integral role of central serotonergic systems in the mo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Majláth, Zsófia, and László Vécsei. "A kinureninrendszer és a stressz." Orvosi Hetilap 156, no. 35 (August 2015): 1402–5. http://dx.doi.org/10.1556/650.2015.30246.

Testo completo
Abstract (sommario):
The kynurenine pathway is the main route of tryptophan degradation which gives rise to several neuroactive metabolites. Kynurenic acid is an endogenous antagonist of excitatory receptors, which proved to be neuroprotective in the preclinical settings. Kynurenines have been implicated in the neuroendocrine regulatory processes. Stress induces several alterations in the kynurenine metabolism and this process may contribute to the development of stress-related pathological processes. Irritable bowel disease and gastric ulcer are well-known disorders which are related to psychiatric comorbidity an
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Mieszkowski, Jan, Paulina Brzezińska, Błażej Stankiewicz, Andrzej Kochanowicz, Bartłomiej Niespodziński, Joanna Reczkowicz, Tomasz Waldziński, et al. "Direct Effects of Vitamin D Supplementation on Ultramarathon-Induced Changes in Kynurenine Metabolism." Nutrients 14, no. 21 (October 25, 2022): 4485. http://dx.doi.org/10.3390/nu14214485.

Testo completo
Abstract (sommario):
In humans, most free tryptophan is degraded via kynurenine pathways into kynurenines. Kynurenines modulate the immune system, central nervous system, and skeletal muscle bioenergetics. Consequently, kynurenine pathway metabolites (KPMs) have been studied in the context of exercise. However, the effect of vitamin D supplementation on exercise-induced changes in KPMs has not been investigated. Here, we analyzed the effect of a single high-dose vitamin D supplementation on KPMs and tryptophan levels in runners after an ultramarathon. In the study, 35 amateur runners were assigned into two groups:
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Zakharov, Gennady A., Alexander V. Zhuravlev, Tatyana L. Payalina, Nikolay G. Kamyshev, and Elena V. Savvateeva-Popova. "The influence of D. melanogaster mutations of the kynurenine pathway of tryptophan metabolism on locomotor behavior and expression of genes belonging to glutamatergic and cholinergic systems." Ecological genetics 9, no. 2 (June 15, 2011): 65–73. http://dx.doi.org/10.17816/ecogen9265-73.

Testo completo
Abstract (sommario):
Disbalance of kynurenines produced by Drosophila mutations of the kynurenine pathway of tryptophan metabolism influences the locomotor behavior in larvae. The most pronounced is the effect of accumulation of kynurenic acid in the mutant cinnabar manifested as sharp reduction of general level of locomotor activity. The mutations seem to act through modulatory influences of kynurenines on signal cascades governed by ionotropic glutamatergic and cholinergic receptors. Expression of receptor genes in the mutants shows age-related changes pointing to gradual evolvement of consequences of kynurenine
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Theofylaktopoulou, Despoina, Arve Ulvik, Øivind Midttun, Per Magne Ueland, Stein Emil Vollset, Ottar Nygård, Steinar Hustad, Grethe S. Tell та Simone J. P. M. Eussen. "Vitamins B2and B6as determinants of kynurenines and related markers of interferon-γ-mediated immune activation in the community-based Hordaland Health Study". British Journal of Nutrition 112, № 7 (8 серпня 2014): 1065–72. http://dx.doi.org/10.1017/s0007114514001858.

Testo completo
Abstract (sommario):
Vitamins B2and B6are cofactors in the kynurenine pathway. Many of the kynurenines are neuroactive compounds with immunomodulatory effects. In the present study, we aimed to investigate plasma concentrations of vitamins B2and B6as determinants of kynurenines and two markers of interferon-γ-mediated immune activation (kynurenine:tryptophan ratio (KTR) and neopterin). We measured the concentrations of vitamins B2and B6vitamers, neopterin, tryptophan and six kynurenines (i.e. kynurenine, anthranilic acid, kynurenic acid, 3-hydroxykynurenine, 3-hydroxyanthranilic acid and xanthurenic acid) in plasm
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Martin, Kyle S., Michele Azzolini, and Jorge Lira Ruas. "The kynurenine connection: how exercise shifts muscle tryptophan metabolism and affects energy homeostasis, the immune system, and the brain." American Journal of Physiology-Cell Physiology 318, no. 5 (May 1, 2020): C818—C830. http://dx.doi.org/10.1152/ajpcell.00580.2019.

Testo completo
Abstract (sommario):
Tryptophan catabolism through the kynurenine pathway generates a variety of bioactive metabolites. Physical exercise can modulate kynurenine pathway metabolism in skeletal muscle and thus change the concentrations of select compounds in peripheral tissues and in the central nervous system. Here we review recent advances in our understanding of how exercise alters tryptophan-kynurenine metabolism in muscle and its subsequent local and distal effects. We propose that the effects of kynurenine pathway metabolites on skeletal muscle, adipose tissue, immune system, and the brain suggest that some o
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Ashoura, Norah E., Joseph Dekker, Todd A. Triplett, Kendra Garrison, John Blazeck, Christos Karamitros, Candice Lamb, et al. "The Force Awakens: Illuminating the Role of Kynurenine in Cancer Progression and Treatment." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 240.16. http://dx.doi.org/10.4049/jimmunol.204.supp.240.16.

Testo completo
Abstract (sommario):
Abstract Cancer is the second leading cause of death in the United States, with an estimated 40% of all Americans expected to be diagnosed with cancer in their lifetime. Despite progress in treatment options, major obstacles in current therapies must be overcome to limit their harmful side effects on patients. To evade immune clearance, many cancers elevate tryptophan (Trp) catabolism in the tumor microenvironment (TME) by upregulating the enzyme indoleamine 2,3-dioxygenase (IDO). As a result, cancer cells (1) monopolize extracellular tryptophan and (2) release L-kynurenine into the TME, an in
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Schlittler, Maja, Michel Goiny, Leandro Z. Agudelo, Tomas Venckunas, Marius Brazaitis, Albertas Skurvydas, Sigitas Kamandulis, et al. "Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans." American Journal of Physiology-Cell Physiology 310, no. 10 (May 15, 2016): C836—C840. http://dx.doi.org/10.1152/ajpcell.00053.2016.

Testo completo
Abstract (sommario):
Physical exercise has emerged as an alternative treatment for patients with depressive disorder. Recent animal studies show that exercise protects from depression by increased skeletal muscle kynurenine aminotransferase (KAT) expression which shifts the kynurenine metabolism away from the neurotoxic kynurenine (KYN) to the production of kynurenic acid (KYNA). In the present study, we investigated the effect of exercise on kynurenine metabolism in humans. KAT gene and protein expression was increased in the muscles of endurance-trained subjects compared with untrained subjects. Endurance exerci
Gli stili APA, Harvard, Vancouver, ISO e altri
Più fonti

Tesi sul tema "Kynurenine - Metabolism"

1

Owe-Young, Robert School of Medicine UNSW. "Kynurenine pathway metabolism at the blood-brain barrier." Awarded by:University of New South Wales. School of Medicine, 2006. http://handle.unsw.edu.au/1959.4/26183.

Testo completo
Abstract (sommario):
A major product of HIV-infected and cytokine-stimulated monocytic-lineage cells is quinolinic acid (QUIN), a neurotoxic metabolite of the kynurenine pathway (KP) of L-tryptophan (L-Trp) metabolism. Despite the large number of neurotoxins found in HIV patients with AIDS Dementia Complex (ADC), only QUIN correlates with both the presence and severity of ADC. With treatment, cerebrospinal fluid (CSF) QUIN concentrations decrease proportionate to the degree of clinical and neuropsychological improvement. As endothelial cells (EC) of the blood-brain barrier (BBB) are the first brain-associated cell
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Skouras, Christos. "Kynurenine metabolism and organ dysfunction in human acute pancreatitis." Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/28898.

Testo completo
Abstract (sommario):
BACKGROUND: Acute pancreatitis (AP) is a sterile initiator of systemic inflammation that can trigger multiple organ dysfunction syndrome (MODS). In the acute phase of AP, the kynurenine pathway of tryptophan metabolism plays an important role in the genesis of AP-MODS in experimental animal models, but it is unknown whether the pathway is activated in human AP. Human data are required to support the rationale for kynurenine 3- monooxygenase (KMO) inhibition as a treatment for AP-MODS and reinforce the translational potential. Additionally, as respiratory dysfunction is frequent in severe AP, t
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Milne, Gavin D. S. "Inhibition studies of kynurenine 3-monooxygenase." Thesis, University of St Andrews, 2013. http://hdl.handle.net/10023/4101.

Testo completo
Abstract (sommario):
Kynurenine 3-monooxygenase (K3MO) lies on the kynurenine pathway, the major pathway for the catabolism of L-tryptophan. It converts kynurenine to 3-hydroxy kynurenine. Inhibition of K3MO is important in several neurological diseases and there is evidence that inhibition of K3MO could also be targeted for the prevention of multiple organ failure, secondary to acute pancreatitis. A structure activity relationship based upon the 1,2,4-oxadiazoles motif was carried out which revealed amide 207 as an inhibitor of P. fluorescens K3MO. Further structure activity relationships were developed based upo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Pisar, Mazura Md. "The role of kynurenine metabolism in the development of the central nervous system." Thesis, University of Glasgow, 2014. http://theses.gla.ac.uk/5550/.

Testo completo
Abstract (sommario):
Prenatal exposure to maternal infection has been thought as a major risk factor for neurodevelopmental brain damage and thus contributes to the pathophysiology of neurodegenerative diseases including schizophrenia and autism. The mechanisms of aberrant neurodevelopmental processes on the offspring, in which primary cerebral insults occur during early brain development, are not fully understood. In the present investigation, maternal infection was modelled in timed-pregnant rats at embryonic day (E) 14, 16 and 18 by administering intraperitoneal injections of polyriboinosinic-polyribocytidilic
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Marchi, Alexandre Froes. "Produção de quinurenina em modelos experimentais de restrição de sono e obesidade." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/9/9141/tde-03062015-165904/.

Testo completo
Abstract (sommario):
A via das Quinureninas (Via Quin) representa a principal via catabólica do metabolismo do triptofano (Trp) e é essencial para diversos processos fisiológicos. No fígado, o Trp é catalisado por triptofano 2,3-dioxigenase (TDO) quinurenina (Quin). A mesma reação também pode ser catalisada pela enzima indolamina 2,3-dioxigenase (IDO), produzida por células imunológicas. Em alguns processos patológicos, há um aumento do consumo de Trp pela Via Quin, que gera compostos que estão relacionados ao processo de imunotolerância. No presente estudo, foram selecionados dois modelos que mimetizam situações
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Yan, Edwin B., Tony Frugier, Chai K. Lim, Benjamin Heng, Gayathri Sundaram, May Tan, Jeffrey V. Rosenfeld, David W. Walker, Gilles J. Guillemin, and Maria C. Morganti-Kossmann. "Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans." BioMed Central, 2015. http://hdl.handle.net/10150/610324.

Testo completo
Abstract (sommario):
ABSTRACT: During inflammation, the kynurenine pathway (KP) metabolises the essential amino acid tryptophan (TRP) potentially contributing to excitotoxicity via the release of quinolinic acid (QUIN) and 3-hydroxykynurenine (3HK). Despite the importance of excitotoxicity in the development of secondary brain damage, investigations on the KP in TBI are scarce. In this study, we comprehensively characterised changes in KP activation by measuring numerous metabolites in cerebrospinal fluid (CSF) from TBI patients and assessing the expression of key KP enzymes in brain tissue from TBI victims. Acute
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Jonker, Anneliene. "Synthetic Lethality and Metabolism in Ewing Sarcoma : Knowledge Through Silence." Thesis, Paris 11, 2014. http://www.theses.fr/2014PA11T039/document.

Testo completo
Abstract (sommario):
Le sarcome de Ewing est la seconde tumeur pédiatrique de l’os la plus fréquente. Elle est caractérisée par une translocation chromosomique résultant à la fusion de EWSR1 avec un membre de la famille ETS. Chez 85% des patients, cette fusion conduit à l’expression de la protéine chimérique EWS-FLI1 qui est l’oncogène majeur de ce sarcome. Ce dernier agit principalement par son action transcriptionelle sur des cibles qui lui sont propres. Au niveau thérapeutique, le sarcome d’Ewing est traité par chimiothérapie, chirurgie locale et par radiothérapie. La survie à long terme des patients est de l’o
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Vallius, Laura I. "Modulating the immune system by amino acid depletion : IDO and beyond." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:eb1a1987-4121-4042-be82-2aafb67c9941.

Testo completo
Abstract (sommario):
Amino acid availability plays an important role in modulating the activity of T-cells. One of the pathways employed by T-cells to sense nutrient levels is the “mammalian target of rapamycin” (mTOR) pathway that is inhibited in response to nutrient depletion. Indoleamine 2,3-dioxygenase (IDO) is the first and rate-limiting enzyme along the tryptophan catabolising kynurenine pathway. T-cells are very sensitive to lack of this essential amino acid in their microenvironment and this confers strong immunomodulatory properties to cells expressing active IDO. It therefore has a significant physiologi
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Mizdrak, Jasminka. "Human lens chemistry: UV filters and age-related nuclear cataract." Australia : Macquarie University, 2007. http://hdl.handle.net/1959.14/16855.

Testo completo
Abstract (sommario):
"A thesis submitted in partial fulfillment of the requirements for the award of the degree of Doctor of Philosophy".<br>Thesis (PhD) -- Macquarie University, Division of Environmental and Life Sciences, Dept. of Chemistry and Biomolecular Sciences, 2007.<br>Bibliography: p. 243-277.<br>Introduction -- A convenient synthesis of 30HKG -- Facile synthesis of the UV filter compounds 30HKyn and AHBG -- Synthesis, identification and quantification of novel human lens metabolites -- Modification of bovine lens protein with UV filters and related metabolites -- Effect of UV light on UV filter-treated
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Boulet-Le, Gouar Lysiane. "Etude de la voie catabolique du tryptophane dans différentes conditions pathologiques : exemple de la phénylcétonurie et perspectives dans les maladies cardiovasculaires Is tryptophan metabolism involved in sleep apnea-relatedcardiovascular co-morbidities and cancer progression? Neuropathology of Kynurenine Pathway of Tryptophan Metabolism Simultaneous determination of tryptophan and 8 metabolites in humanplasma by liquid chromatography/tandem mass spectrometry." Thesis, Université Grenoble Alpes, 2020. http://www.theses.fr/2020GRALV040.

Testo completo
Abstract (sommario):
Le métabolisme du tryptophane (Trp) a été investigué dans différentes pathologies, incluant les maladies cardiovasculaires, la cancérologie et les maladies neurodégénératives. Le Trp, acide aminé essentiel, est catabolisé en périphérie et au niveau central selon 2 voies : celle des kynurénines, quantitativement majoritaire et impliquée dans les cardiopathies et la tolérance immune, et celle de la sérotonine, connue pour son implication dans la dépression et le sommeil. Dans le cadre de ce travail, nous nous sommes intéressés à l’implication de cette voie métabolique dans la phénylcétonurie (PC
Gli stili APA, Harvard, Vancouver, ISO e altri
Più fonti

Libri sul tema "Kynurenine - Metabolism"

1

Robert, Schwarcz, Young Simon N, and Brown Raymond R, eds. Kynurenine and serotonin pathways: Progress in tryptophan research. New York: Plenum Press, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Lázló, Vécsei, ed. Kynurenines in the brain: From experiments to clinics. Hauppauge, NY: Nova Science Publishers, 2005.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Mirza, Sarwarbeg. The hepatic and the peripheral metabolism of tryptophan via the kynurenine pathway in children with biliary atresiaand with orthotopic liver transplant: The assessment of the relationship between the levels of the kynurenine metabolites, neopterin, biopterin and liver function tests. [Guildford]: University of Surrey, 1995.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Mittal, Sandeep. Targeting the Broadly Pathogenic Kynurenine Pathway. Springer, 2016.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Mittal, Sandeep. Targeting the Broadly Pathogenic Kynurenine Pathway. Springer, 2015.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Mittal, Sandeep. Targeting the Broadly Pathogenic Kynurenine Pathway. Springer, 2015.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Schwarcz, Robert, Simon N. Young, and Raymond R. Brown. Kynurenine and Serotonin Pathways: Progress in Tryptophan Research. Springer, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Schwarcz, Robert, Simon N. Young, and Raymond R. Brown. Kynurenine and Serotonin Pathways: Progress in Tryptophan Research. Springer London, Limited, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

(Editor), Robert Schwarcz, Simon N. Young (Editor), and Raymond R. Brown (Editor), eds. Kynurenine and Serotonin Pathways (Advances in Experimental Medicine and Biology). Springer, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri

Capitoli di libri sul tema "Kynurenine - Metabolism"

1

Rudzite, V., and E. Jurika. "Kynurenine and Lipid Metabolism." In Advances in Experimental Medicine and Biology, 463–66. Boston, MA: Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4684-5952-4_45.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Shibata, Katsumi. "Nutritional Aspects of Tryptophan Metabolism." In Targeting the Broadly Pathogenic Kynurenine Pathway, 31–43. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3_3.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Guillemin, Gilles J., Stephen J. Kerr, George A. Smythe, Patricia J. Armati, and Bruce J. Brew. "Kynurenine Pathway Metabolism in Human Astrocytes." In Advances in Experimental Medicine and Biology, 125–31. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4709-9_18.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Juhász, Csaba, and Sandeep Mittal. "Molecular Imaging of Tryptophan Metabolism in Tumors." In Targeting the Broadly Pathogenic Kynurenine Pathway, 373–89. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3_28.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Lim, Chai K., and Gilles J. Guillemin. "The Next Decade in Tryptophan Metabolism Research." In Targeting the Broadly Pathogenic Kynurenine Pathway, 419–25. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3_31.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Michelhaugh, Sharon K., Anthony R. Guastella, and Sandeep Mittal. "Overview of the Kynurenine Pathway of Tryptophan Metabolism." In Targeting the Broadly Pathogenic Kynurenine Pathway, 3–9. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3_1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Frédérick, Raphaël. "Inhibition of the Kynurenine Pathway of Tryptophan Metabolism." In Targeting the Broadly Pathogenic Kynurenine Pathway, 393–406. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3_29.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Rudzite, V., G. Sileniece, D. Liepina, A. Dalmane, and R. Zirne. "Impairment of Kynurenine Metabolism in Cardiovascular Disease." In Advances in Experimental Medicine and Biology, 663–67. Boston, MA: Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4684-5952-4_89.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Gostner, Johanna M., Kathrin Becker, Barbara Sperner-Unterweger, Florian Überall, Dietmar Fuchs, and Barbara Strasser. "Role of Tryptophan Metabolism in Mood, Behavior, and Cognition." In Targeting the Broadly Pathogenic Kynurenine Pathway, 75–89. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3_6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Badawy, Abdulla A. B. "Tryptophan Metabolism and the Hepatic Kynurenine Pathway in Health and Disease." In Targeting the Broadly Pathogenic Kynurenine Pathway, 11–30. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3_2.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri

Atti di convegni sul tema "Kynurenine - Metabolism"

1

Gosker, Harry R., Gerard Clarke, John F. Cryan, and Annemie M. Schols. "Impaired skeletal muscle kynurenine metabolism in patients with COPD." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa940.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Castro-Portuguez, Raul, Samuel Freitas, and George L. Sutphin. "Abstract LB-241: Kynurenine metabolism as a biomarker and therapeutic target in hepatocellular carcinoma (HCC)." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-lb-241.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Coma, Silvia, Jill Cavanaugh, James Nolan, Jeremy Tchaicha, Karen McGovern, Everett Stone, Candice Lamb, et al. "Abstract 3757: Targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-3757.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Subramanian, Chitra, Thekkelnaycke M. Rajendiran, Tanu Soni, and Mark S. Cohen. "Abstract 5481: Targeting the kynurenine pathway as a novel metabolic treatment for head and neck cancer." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5481.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Zhang, Michelle, Everett Stone, Todd A. Triplett, Kendra Triplett, Candice Lamb, Christos S. Karamitros, John Blazek, George Georgiou, and Mark G. Manfredi. "Abstract 5570: A novel approach to targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-5570.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!